Written question asked by Lord Clement-Jones (Liberal Democrat), in the House of Lords. It was due for an answer on Wednesday, 30 April 2003. It was answered by Baroness Andrews (Labour) on Wednesday, 30 April 2003.
Andrews, Baroness
- Question
- In the light of the recent discontinuation of human-derived follicle-stimulating hormone (Metrodin High Purity) by the Committee on Safety of Medicines because of the posed risk of vCJD, whether they have assessed the cost of possible compensation claims from transfusion of vCJD through United Kingdom-sourced fresh frozen plasma. [HL 2554].
Secondary information
- Type
- Written question
- Reference
- HL 2554; 647 c114WA
- Session
- 2002-03
- Subjects
- Compensation Costs Contamination Blood Blood transfusions CJD
Librarians' tools
- Timestamp
- 2013-11-25 07:27:16 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_813548
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_813548
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_813548